2019 MAIN CONFERENCE POSTER PRESENTATIONS
Room: Hall B, Moscone South Convention Center
Presenting Monday – Wednesday
Poster Presenters noted with † are Conference Speakers. Poster Presenters noted with * are Student Fellows.
Academia Sinica
1. Random and Aligned Electrospun PLGA Nanofibers for Cancer Cell Isolation; Presented by Peilin C.
AmpTec GmbH
2. Synthetic mRNAs in Clinical Trials: Manufacturing of High Quality GMP-Grade Synthetic mRNAs; Presented by Guido K.
Anchor Molecular, Inc.
3. Characterization of DNA-Depleted Plasma and Evaluation of Plasma-Based Quality Control for Monitoring the DNA Extraction; Presented by Yabin L.
AstraZeneca
4. Development and Validation of a Deep Learning Algorithm for PD-L1 Scoring in Tumour Cells and Immune Cells; Presented by Michel V.
Athena Consulting
5. GEOmAtik™: Automated Platform for Mining and Classification of Individual Sample Datasets of NCBI GEO; Presented by Madhura V.
BC Platforms
6. Massively Parallel Multi-Chip Imputation Pipeline and Genomic Data Warehouse Apply a Novel Genomic Tiling Technology; Presented by Ellen S.
Beckman Coulter, Inc.
7. 1-Hour Easy Intracellular Flow Cytometry Assay to Detect Circulating Tumor Cells Without Pre-Enrichment Step; Presented by Vashti L.
Beckman Coulter, Inc.
8. Automated Library Preparation for the MCI Advantage Cancer Panel at Miami Cancer Institute Utilizing the Beckman Coulter Biomek i5 Span-8 Liquid Handler; Presented by Sahar S.
Beckman Coulter, Inc.
9. Extraction of cfDNA in a New Scalable and Automatable Method; Presented by Sahar S.
BioFluidica
10. Detection of CTCs from Whole Blood of Lung Cancer Patients Using Automated Liquid Scan Microfluidic Chip Technology; Presented by Jerry L.
BioFluidica
11. Isolation of Cancer Cell-Derived Extracellular Vesicles Utilizing an Automated Microfluidic Platform; Presented by Jerry L.
BioIVT
12. Key Determinants for Successful Formalin Fixed Paraffin Embedded Tissue Sample Prep for Downstream Applications; Presented by Chanel S.
Bioo Scientific, a PerkinElmer Company
13. A Comprehensive, Automated Extraction and Downstream NGS Library Workflow for cfDNA Inputs; Presented by Kyoko K.
Biotech Support Group, LLC
14. New Cancer Therapeutic Strategies are Proposed Based on Evidence from Stroma Liquid Biopsy™ Biomarkers; Presented by Matthew K.
Biotech Support Group, LLC
15. AlbuVoid™ Enrichment and Antibody Depletion - Tackling the Challenges of Serum Proteomics Part II; Presented by Matthew K.
California Institute of Technology
16. A Rapid Phenotypic Test for Beta-Lactam Antibiotic Susceptibility; Presented by Eric L.*
Charles R. Drew University of Medicine and Science
17. Investigating Transcriptomic and Epigenomic Mechanisms in Trastuzumab Resistance; Presented by Pranabananda D.
Commissariat à l’Énergie atomique et aux Énergies Alternatives (CEA)
18. Automated and Accurate Diagnostic Tests Using Microfluidic Devices; Presented by Fabrice N.
Commissariat à l’Énergie atomique et aux Énergies Alternatives (CEA)
19. Microfluidic Standardization: Status and Roadmap; Presented by Nicolas V.
CONICET - National Scientific and Technical Research Council
20. OncoSens Toolkit: A Data Science-Driven Approach to Reporting Somatic Variants for Precision Oncology; Presented by Diego L.
Creatv MicroTech, Inc.
21. Changes in the Type of Circulating Cancer Associated Macrophage Like Cells During and After Radiation Therapy is Associated with Progression in Thoracic Cancers; Presented by Daniel A.
Creatv MicroTech, Inc.
22. Real Time Monitoring of Solid Tumor Progression Using Circulating Stromal Cells in Early and Late Stage Disease; Presented by Cha-Mei T.
Creatv MicroTech, Inc.
23. Cancer Associated Macrophage-Like (CAMLs) Cells in Circulation Predict Progression and Survival in All Stages of Solid Tumors; Presented by Cha-Mei T.
Cyber Forza, Inc.
24. Adaptive and Cognitive Artificial Intelligence Based Cyber Security Solutions for the Molecular Bio Tech Industry; Presented by Venkat R.
Daegu-Gyeongbuk Medical Innovation Foundation
25. Mismatched Target Catching Nanosurface for a Point of Care Precision Diagnostics; Presented by Joong Hyun K.
DiaCarta
26. XNA-Based OptiSeq™ NGS Panel for Colorectal Cancer Diagnostic Applications; Presented by Michael S.
DiaCarta
27. Novel XNA Molecular Clamp Application in NGS Diagnostic Platform OptiSeq™ Cancer Panels; Presented by Ke Z.
Discovery Life Sciences
28. Multiparametric Flow Cytometry Analysis of Checkpoint Inhibitors (PD-1 and PD-L1) in Dissociated Tumor and Normal Tissues; Presented by Shawn F.†
Future Diagnostics Solutions
29. A Miniature Bio-Photonics Companion Diagnostics Platform for Reliable Cancer Diagnosis and Treatment Monitoring (BioCDx); Presented by Ernst L.
GlaxoSmithKline
30. Histopathological Image Analysis for Necroptosis Biomarkers Research; Presented by Haydee L.
GSI Technology, Inc.
31. Hardware-Accelerated Drug Discovery; Presented by George W.
Hitachi, Ltd.
32. High-Precision Dispensing Technology for Micro-Volume Blood Testing; Presented by Takahiro A.
Hitachi, Ltd.
33. Digital PCR Combined with Melting Curve Analysis for Highly Multiplexed Genotyping; Presented by Tatsuo N.
ImmunXperts SA
34. In Vitro Assays for Immuno-Oncology Candidate Selection and Optimization; Presented by Amin O.
Indian Institute of Science (IISc)
35. Paper Machines for Rapid Detection of Tuberculosis at the Point-of-Care; Presented by Navjot K.*
Kobe University
36. Protein Recognition Spots Extraction by Biclustering Algorithm BISES; Presented by Takenao O.
Korea Institute of Machinery and Materials
37. Injection Molded Plastic Micro-Fluidic Platform for Blood Sample Preparation; Presented by Yeong-Eun Y.
Korea Institute of Science and Technology
38. High Sensitive and Simple Digital Real Time PCR Platform; Presented by Sang Kyung K.
Korea Research Institute of Standards and Science
39. Assessment of Sensitivity and Accuracy in Quantification of EGFR Mutations Using Droplet Digital PCR; Presented by Young-Kyung
Korea Research Institute of Standards and Science
40. Novel Extracellular Vesicles Support Cell Proliferation; Presented by Ji Youn L.
Linkou Chang Gung Memorial Hospital
41. The Association Between Graves' Disease and Gut Microbiota; Presented by Shih-Cheng C.
Linkou Chang Gung Memorial Hospital
42. PIK3CA Pathway and CTNNB1 Determine Poor Response of Cetuximab in Right-Sided Metastatic Colorectal Cancer; Presented by Pi-Yueh C.
Mayo Clinic
43. Cell-Free DNA Prenatal Screen Pipeline for Trisomy and Sex Chromosome Aneuploidy at the Mayo Clinic; Presented by Carlos S.
Medical University of Vienna
44. Molecular Characterization of Circulating Tumor Cells Enriched by a Microfluidic Platform in Patients with Small-Cell Lung Cancer; Presented by Robert Z.
Metagenics, Inc.
45. Personalized Lifestyle Intervention for Improving Functional Health Outcomes in Women: LIFE-HOUSE Study Utilizing an N-of-1 Tent-Umbrella-Bucket Design; Presented by Sara G.
MLL Munich Leukemia Laboratory
46. Whole Genome Sequencing as a Single Diagnostic Test for Classification and Personalized Treatment Recommendation in Hematological Neoplasms: A Study with 3240 Cases; Presented by Niroshan N.
NanoHelix Co., Ltd.
47. Development of Hyper-Multiplex Real-Time PCR Method Based on 2D Labeling and Its Application to Rice Varieties Determination; Presented by Minsu K.
National Cheng Kung University
48. Fas-Associated Factor 1 (FAF1) Binds to Mineralocorticoid Receptor (MR) Through Its SUMO-Interacting Motifs and Negatively Modulates MR Transcriptional Activity; Presented by Ding-Yen L.
National Cheng Kung University
49. Methylated Circulating Nucleic Acids as a Potential Biomarker in Neurodegenerative Diseases; Presented by Kuen-Jer T.
National Science and Technology Development Agency
50. Development of Microneedle Platforms for High-Accuracy Diagnosis of Latent Tuberculosis Infection; Presented by Jeerapond L.
National Tsing Hua University
51. The Algorithm for Training Process in Biomarkers Discovery for Blood Biopsy; Presented by Ian H.
National University of Singapore
52. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study*; Presented by Yoon Pin L.
NVIGEN, Inc.
53. Magnetic and Fluorescent Magnetic Nanobeads Enabled Comprehensive Circulating Marker Capture and Detection Technology to Advance Personalized Medicine; Presented by Aihua F.
Paragon Genomics, Inc.
54. Tumor Mutational Burden (TMB) Analysis Using an Ultra-High Multiplexed 20,000-Amplicon NGS Panel in a Rapid 4-Hour Workflow; Presented by Lucie L.
Paragon Genomics, Inc.
55. Detecting Rare Mutations in Cell-Free DNA by Integrating an Ultrafast Amplicon-Based Targeted Library Preparation Method with Double-Stranded Unique Molecular Identifiers; Presented by Yang Lily L.
Paragon Genomics, Inc.
56. Hereditary Cancer Panel for Determining Genetic Predispositions Using a Rapid and Streamlined Amplicon-Based NGS Workflow; Presented by Kathryn P.
PerkinElmer
57. Characterization of AAV Structure: Capsid Proteins and Nucleic Acid Composition on LabChip GXII Touch Platform; Presented by Natalia R.
Portola High School
58. PocketOnco: A Novel CoreML-Based iOS App for the Diagnosis and Prognosis of Colorectal, Breast, and Skin Cancer Using Multilayered Convolutional Neural Network Algorithms; Presented by Stephanie Z.* & Patrick C.*
Promega Corporation
59. Quantitative Cell-Based Bioassays to Advance Individual and Combination Immune Checkpoint Immunotherapy; Presented by Neal C.
Quark Biosciences, Inc.
60. Evaluation of dqPCR Platform as a Liquid Biopsy ctDNA Diagnostic Tool for NSCLC Patients; Presented by Max W.
Rancho Biosciences
61. Aggregation and Integration of UK Biobank Phenotype Data for Downstream Analysis; Presented by Tatiana K.
Rancho Biosciences
62. Data Deluge: Challenges and Solutions for Implementing a Precision Medicine Approach to Create the TRACK-TBI Information Commons; Presented by Tatiana K.
RareCyte, Inc.
63. Multi-Parameter Tissue Section Imaging and Retrieval of Image-Defined Micro-Regions for RNA Sequencing Using the RareCyte® Platform; Presented by Nolan E.
RareCyte, Inc.
64. Single Cell Molecular Characterization and PDL1 Expression Analysis of Model CTCs Using the RareCyte Platform; Presented by Tad G.
ResultWorks LLC
65. Leveraging Data and Innovative Technologies to Achieve R&D Digital Transformation; Presented by Brian H.
ResultWorks LLC
66. Digitally Transforming the Cell Therapy Product Lifecycle; Presented by Bob O.
RNAssist Ltd.
67. A New Generation of Reagents Combining Tissue Fixation and Biomolecule Stabilisation; Presented by Andrew G.
ScreenCell
68. Ex Vivo Expansion of Live CTCs Isolated by Size from Melanoma Patients; Presented by Jessica G.
Slovak Centre of Scientific and Technical Information
69. Dante: Genotyping of Short Tandem Repetitions in NGS Data; Presented by Jaroslav B.
Slovak Centre of Scientific and Technical Information
70. Fragment Size Analysis of Whole Genome Based NIPT for Improved Specificity of the Test; Presented by Tomas S.
Stanford University
71. Cell-Cell Interactions Between NK and Breast Cancer Cells; Presented by Bianca F.*
Sun Yat-sen University
72. ELF-1 Expression in Nasopharyngeal Carcinoma Facilitates Proliferation and Metastasis of Cancer Cells via Modulating CCL2/CCR2 Signaling; Presented by Chang-Han C.
Sun Yat-sen University
73. An Actin-Binding Protein ESPN Is an Independent Prognosticator and Regulates Cell Growth for Esophageal Squamous Cell Carcinoma; Presented by Hsin-Ting T.
Swift Biosciences, Inc.
74. A Rapid Library Prep with Enzymatic Shearing for an Improved Next Generation Sequencing Workflow for WGS and Target Enrichment; Presented by Haley F.
Swift Biosciences, Inc.
75. Turbolase: A Radically Streamlined High Throughput Sample Prep to Sequencing Workflow; Presented by Haley F.
Taiwan Semiconductor Research Institute
76. Rapid Determination of Bacterial Antibiotic Susceptibility Using a Hybrid Optofluidic-Electrokinetic Chip; Presented by I-Fang C.
Takara Bio USA, Inc.
77. Next Generation Whole Genome Amplification Methods for CNV and SNV Detection from Single Cells; Presented by Luke S.
Thermo Fisher Scientific
78. DNA-Free Platinum Taq DNA Polymerase for Reliable Microbiome Studies; Presented by Samantha L.
Thermo Fisher Scientific
79. Lyo-Ready SuperScript Reverse Transcriptases: High-Performance Lyophilization-Compatible Enzymes for RT-PCR-Based Assays; Presented by Samantha L.
Tunghai University
80. Effects of Carbonic Anhydrase 8 on Glucose Metabolism in Colorectal Cancer; Presented by Mingli H.
U.S. Naval Research Laboratory
81. Catalytic Nanoparticles to Enhance the Sensitivity of Lateral Flow Immunoassays; Presented by Shawn M.†
U.S. Naval Research Laboratory
82. Development and Tiered Evaluation of Technologies for Multiechelon Diagnostics (MEDx); Presented by Shawn M.†
Uijeongbu St. Mary’s Hospital
83. Recapitulation of GWAS Results for the Smoking Behavior in Korean Males; Presented by Keun-Sang Y.
University of Otago
84. Effective DNA Extraction for Sequencing in Extremely Remote Settings: Pairing PDQeX with MinION and MinIT to Diagnose Cassava Mosaic Virus on East African Farms; Presented by Jo-Ann S.
University of Pittsburgh
85. Understanding the Role of Ciliary Genes in Congenital Heart Disease Pathogenesis; Presented by Kylia W.*
University of Tokyo
86. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS; Presented by Sousuke N.
University of Turku
87. ShAn: An Easy-to-Use Tool for Interactive and Integrated Variant Annotation; Presented by Venkat R.*
Visiopharm
88. Image Analysis and Manual Scoring of PD-L1 in Melanomas Using Physical and Virtual Double Staining; Presented by Crystal F.
Vortex Biosciences
89. Microfluidic Label-Free Isolation and Enumeration of Circulating Tumor Cells from Blood Samples; Presented by Emily L.
Wainamics, Inc.
90. Point-of-Care Diagnostic Testing Device Using Electrochemical-Based Detection; Presented by Ming T.
Wonkwang University
91. Development of a Rapid Fluorescent Immunochromatographic Test to Detect Respiratory Syncytial Virus; Presented by Tien T.
Wonkwang University
92. Development of a Smartphone-Based Rapid Dual Fluorescent Diagnostic System for the Simultaneous Detection of Influenza A and H5 Subtype in Avian Influenza A-Infected Patients; Presented by Seon-Ju Y.
Zeon Specialty Materials, Inc.
93. A Comparison of Cyclo Olefin Polymer with Glass and Other Plastics for the Construction of Molecular Diagnostic Consumable Devices; Presented by Lawrence A.†